Louise Ritz
About
Louise Ritz is a scholar working on Psychiatry and Mental health, Cognitive Neuroscience and Pharmacology.
According to data from OpenAlex, Louise Ritz has authored 37 papers receiving a total of 7.3k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Psychiatry and Mental health, 16 papers in Cognitive Neuroscience and 13 papers in Pharmacology. Recurrent topics in Louise Ritz's work include Autism Spectrum Disorder Research (16 papers), Attention Deficit Hyperactivity Disorder (13 papers) and Treatment of Major Depression (12 papers). Louise Ritz is often cited by papers focused on Autism Spectrum Disorder Research (16 papers), Attention Deficit Hyperactivity Disorder (13 papers) and Treatment of Major Depression (12 papers). Louise Ritz collaborates with scholars based in United States, United Kingdom and Canada. Louise Ritz's co-authors include Stephen R. Wisniewski, Madhukar H. Trivedi, A. John Rush, Diane Warden, Andrew A. Nierenberg, Melanie M. Biggs, Maurizio Fava, Kathy Shores‐Wilson, Barry D. Lebowitz and G.K. Balasubramani and has published in prestigious journals such as New England Journal of Medicine, American Journal of Psychiatry and Journal of the American Academy of Child & Adolescent Psychiatry.
In The Last Decade
Louise Ritz
37 papers receiving 7.0k citations
Hit Papers
Peers
Louise Ritz
Mustafa M. Husain United States
George Niederehe United States
Robert H. Howland United States
Philip T. Ninan United States
Kathy Shores‐Wilson United States
Lauren B. Marangell United States
Frederic M. Quitkin United States
George I. Papakostas United States
Rezvan Ameli United States
Daniel Souery Belgium
Citations per year, relative to Louise Ritz Louise Ritz (= 1×)
peers
Mustafa M. Husain
Countries citing papers authored by Louise Ritz
Since
Specialization
Citations
This map shows the geographic impact of Louise Ritz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Louise Ritz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Louise Ritz more than expected).
Fields of papers citing papers by Louise Ritz
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Louise Ritz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Louise Ritz. The network helps show where Louise Ritz may publish in the future.
Co-authorship network of co-authors of Louise Ritz
This figure shows the co-authorship network connecting the top 25 collaborators of Louise Ritz. A scholar is included among the top collaborators of Louise Ritz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Louise Ritz. Louise Ritz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Scahill, Lawrence David, James T. McCracken, Karen Bearss, et al.. (2011). Design and Subject Characteristics in the Federally-Funded Citalopram Trial in Children with Pervasive Developmental Disorders. Journal of Autism and Developmental Disorders. 42(3). 432–440.
2.
Findling, Robert L., Jacqueline L. Johnson, Jon McClellan, et al.. (2010). Double-Blind Maintenance Safety and Effectiveness Findings From the Treatment of Early-Onset Schizophrenia Spectrum (TEOSS) Study. Journal of the American Academy of Child & Adolescent Psychiatry. 49(6). 583–594.
3.
McCracken, James T., Michael G. Aman, Christopher J. McDougle, et al.. (2010). Possible Influence of Variant of the P-Glycoprotein Gene ( MDR1/ABCB1 ) on Clinical Response to Guanfacine in Children with Pervasive Developmental Disorders and Hyperactivity. Journal of Child and Adolescent Psychopharmacology. 20(1). 1–5.
4.
King, Bryan H., Eric Hollander, Linmarie Sikich, et al.. (2009). Lack of Efficacy of Citalopram in Children With Autism Spectrum Disorders and High Levels of Repetitive Behavior. Archives of General Psychiatry. 66(6). 583–583.
5.
Aman, Michael G., Jill A. Hollway, Christopher J. McDougle, et al.. (2008). Cognitive Effects of Risperidone in Children with Autism and Irritable Behavior. Journal of Child and Adolescent Psychopharmacology. 18(3). 227–236.
6.
Marcus, Sheila M., Kevin Kerber, A. John Rush, et al.. (2008). Sex differences in depression symptoms in treatment-seeking adults: confirmatory analyses from the Sequenced Treatment Alternatives to Relieve Depression study. Comprehensive Psychiatry. 49(3). 238–246.
7.
Scahill, Lawrence David, Michael G. Aman, Christopher J. McDougle, et al.. (2008). Trial Design Challenges When Combining Medication and Parent Training in Children with Pervasive Developmental Disorders. Journal of Autism and Developmental Disorders. 39(5). 720–729.
8.
Sikich, Linmarie, Jean A. Frazier, Jon McClellan, et al.. (2008). Double-Blind Comparison of First- and Second-Generation Antipsychotics in Early-Onset Schizophrenia and Schizo-affective Disorder: Findings From the Treatment of Early-Onset Schizophrenia Spectrum Disorders (TEOSS) Study. American Journal of Psychiatry. 165(11). 1420–1431.
9.
Cook, Ian A., G.K. Balasubramani, Heather Eng, et al.. (2007). Electronic source materials in clinical research: Acceptability and validity of symptom self-rating in major depressive disorder. Journal of Psychiatric Research. 41(9). 737–743.
10.
Rush, A. John, Madhukar H. Trivedi, Stephen R. Wisniewski, et al.. (2006). Bupropion-SR, Sertraline, or Venlafaxine-XR after Failure of SSRIs for Depression. New England Journal of Medicine. 354(12). 1231–1242.
11.
Trivedi, Madhukar H., A. John Rush, Stephen R. Wisniewski, et al.. (2006). Evaluation of Outcomes With Citalopram for Depression Using Measurement-Based Care in STAR*D: Implications for Clinical Practice. American Journal of Psychiatry. 163(1). 28–40.
12.
Scahill, Lawrence David, Michael G. Aman, Christopher J. McDougle, et al.. (2006). AProspective Open Trial of Guanfacine in Children with Pervasive Developmental Disorders. Journal of Child and Adolescent Psychopharmacology. 16(5). 589–598.
13.
Williams, Susan K., Lawrence David Scahill, Benedetto Vitiello, et al.. (2006). Risperidone and Adaptive Behavior in Children With Autism. Journal of the American Academy of Child & Adolescent Psychiatry. 45(4). 431–439.
14.
Warden, Diane, A. John Rush, Madhukar H. Trivedi, et al.. (2005). Quality improvement methods as applied to a multicenter effectiveness trial—STAR*D. Contemporary Clinical Trials. 26(1). 95–112.
15.
Aman, Michael G., L. Eugene Arnold, Christopher J. McDougle, et al.. (2005). Acute and Long-Term Safety and Tolerability of Risperidone in Children with Autism. Journal of Child and Adolescent Psychopharmacology. 15(6). 869–884.
16.
Wisniewski, Stephen R., Heather Eng, Louise Ritz, et al.. (2004). Web-based communications and management of a multi-center clinical trial: the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) project. Clinical Trials. 1(4). 387–398.
17.
Walkup, John T., Michael J. Labellarte, Mark A. Riddle, et al.. (2002). Treatment of Pediatric Anxiety Disorders: An Open-Label Extension of the Research Units on Pediatric Psychopharmacology Anxiety Study. Journal of Child and Adolescent Psychopharmacology. 12(3). 175–188.
18.
Scahill, Lawrence David, James T. McCracken, Christopher J. McDougle, et al.. (2001). Methodological Issues in Designing a Multisite Trial of Risperidone in Children and Adolescents with Autism. Journal of Child and Adolescent Psychopharmacology. 11(4). 377–388.
19.
Arnold, L. Eugene, M. G. Aman, Andrés Martin, et al.. (2000). Assessment in Multisite Randomized Clinical Trials of Patients with Autistic Disorder: The Autism RUPP Network. Journal of Autism and Developmental Disorders. 30(2). 99–111.
20.
Swenson, Karen K., et al.. (1995). Recognition and Evaluation of Oncology-Related Symptoms in the Emergency Department. Annals of Emergency Medicine. 26(1). 12–17.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Mustafa M. Husain Breakdown of academic impact, for papers by George Niederehe Breakdown of academic impact, for papers by Robert H. Howland Breakdown of academic impact, for papers by Philip T. Ninan Breakdown of academic impact, for papers by Kathy Shores‐Wilson Breakdown of academic impact, for papers by Lauren B. Marangell Breakdown of academic impact, for papers by Frederic M. Quitkin Breakdown of academic impact, for papers by George I. Papakostas Breakdown of academic impact, for papers by Rezvan Ameli Breakdown of academic impact, for papers by Daniel Souery